Alexander Mayweg
Managing Director at Versant Ventures
Basel, Basel
Overview
Work Experience
Managing Director
2020 - Current
Partner
2018 - 2020
Venture Partner
2017 - 2017
Entrepreneur in Residence
2016 - 2016
Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Founding CSO
2017
Board Director
2017
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Raised $272,100,000.00 from Nextech Invest, Biotechnology Value Fund, Logos Capital, Perceptive Advisors, Invus, Wellington Management, Versant Ventures, New Enterprise Associates, Roche Venture Fund and City Hill Ventures.
Board Member
2017
President and CSO
2017
Ridgeline Therapeutics is emerging biotechnology developing new drugs to cure Type 2 diabetes, muscular, age-related muscle degeneration.
Board Director
2018
Board Director
2018
Global Head of Medicinal Chemistry | Principal Leader, VP
2013 - 2016
Global head of medicinal chemistry across Basel, Shanghai and New York research sites.
Head of Antibiotics Disease Area (Additional Responsibility) | Senior Leader
2012 - 2014
Head of antibiotics disease area including strategy, biology and chemistry in Shanghai and Basel
Site Head of Medicinal Chemistry | Senior Leader
2011 - 2013
Site Head of the medicinal and computational chemistry departments at Roche R&D Center Shanghai
Section Head in Discovery Chemistry Technologies & Metabolic Diseases | Leader
2011 - 2011
International assignment as Section Head of med chem III and computational chemistry departments
Group Leader, Medicinal Chemistry | Principal Scientist
2009 - 2011
Leader of four laboratory lab teams in Medicinal Chemistry 1
Short Term International Assignment
2010 - 2010
One month assignment at Indian CRO
Project Leader, Medicinal Chemistry | Senior Scientist
2006 - 2009
Project leader in medicinal chemistry in Cardiovascular and Metabolism
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on
Project Leader, Research Informatics (Additional Responsibility) | Senior Scientist
2004 - 2006
Project leader of new informatics Knowledge Capture Project
Laboratory Head, Medicinal Chemistry | Scientist
2003 - 2006
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on
Medicinal Chemistry Placement | Research Chemist
1996 - 1997
Education
Post Doc
2001 - 2003
D.Phil.
1998 - 2001
B.Sc.
1994 - 1998
Abitur (IB equivalent)
1989 - 1994